Last updated on May 2020

Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Hepatitis C virus
  • Age: Between 12 - 100 Years
  • Gender: Male or Female

Key Inclusion Criteria:

  • Individuals aged 12 years and older who are living in Korea
  • Adult individuals who have been informed of all pertinent aspects of the study and have voluntarily signed a Personal Information Protection Act (PIPA) consent form; Pediatric individuals who have the individuals' legally authorized representatives sign the PIPA consent form

Key Exclusion Criteria:

  • Individuals treated with Harvoni outside of the approved prescribing information in Korea
  • Individuals who have a contra-indication to Harvoni
  • Individuals who have a contra-indication to ribavirin
  • Pregnant or breastfeeding women
  • Individuals who have previously been administered Harvoni
  • Individuals participating in a concurrent HCV clinical trial
  • Individuals planning on leaving the country during the study period

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.